Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q4748723> ?p ?o }
Showing triples 1 to 36 of
36
with 100 triples per page.
- Q4748723 subject Q5920511.
- Q4748723 subject Q7579524.
- Q4748723 subject Q8255322.
- Q4748723 subject Q8616489.
- Q4748723 abstract "Amrubicin (INN; previously known as SM-5887) is an anthracycline used in the treatment of lung cancer. It is marketed in Japan since 2002 by Sumitomo Pharmaceuticals under the brand name Calsed.Amrubicin acts by inhibiting topoisomerase II, and has been compared in clinical trials with topotecan, a Topoisomerase I inhibitor. It has also been studied for the treatment of bladder carcinoma and gastric cancer.".
- Q4748723 atcPrefix "L01".
- Q4748723 atcSuffix "DB10".
- Q4748723 casNumber "110267-81-7".
- Q4748723 fdaUniiCode "93N13LB4Z2".
- Q4748723 iupacName "(7S,9S)-9-Acetyl-9-amino-7-[(2S,4S,5R)-4,5-dihydroxyoxan-2-yl]oxy-6,11-dihydroxy-8,10-dihydro-7H-tetracene-5,12-dione".
- Q4748723 pubchem "178149".
- Q4748723 thumbnail Amrubicin.png?width=300.
- Q4748723 wikiPageWikiLink Q411991.
- Q4748723 wikiPageWikiLink Q417589.
- Q4748723 wikiPageWikiLink Q419953.
- Q4748723 wikiPageWikiLink Q47912.
- Q4748723 wikiPageWikiLink Q5920511.
- Q4748723 wikiPageWikiLink Q640448.
- Q4748723 wikiPageWikiLink Q7579524.
- Q4748723 wikiPageWikiLink Q824258.
- Q4748723 wikiPageWikiLink Q8255322.
- Q4748723 wikiPageWikiLink Q8616489.
- Q4748723 atcPrefix "L01".
- Q4748723 atcSuffix "DB10".
- Q4748723 casNumber "110267".
- Q4748723 iupacName "-9".
- Q4748723 pubchem "178149".
- Q4748723 unii "93".
- Q4748723 type ChemicalSubstance.
- Q4748723 type Drug.
- Q4748723 type ChemicalObject.
- Q4748723 type Thing.
- Q4748723 type Q8386.
- Q4748723 comment "Amrubicin (INN; previously known as SM-5887) is an anthracycline used in the treatment of lung cancer. It is marketed in Japan since 2002 by Sumitomo Pharmaceuticals under the brand name Calsed.Amrubicin acts by inhibiting topoisomerase II, and has been compared in clinical trials with topotecan, a Topoisomerase I inhibitor. It has also been studied for the treatment of bladder carcinoma and gastric cancer.".
- Q4748723 label "Amrubicin".
- Q4748723 depiction Amrubicin.png.